-----------------------
                                                               OMB APPROVAL
                                                         -----------------------
                                                         OMB Number:   3235-0058
                                                         Expires: April 30, 2009
                                                         Estimated average
                                                         burden hours per
                                                         response.......... 2.50
                                                         -----------------------

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

                                  (Check one):

                    [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K
            [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR

                       For Period Ended: January 31, 2009

                       [] Transition Report on Form 10-K
                       [] Transition Report on Form 20-F
                       [] Transition Report on Form 11-K
                       [] Transition Report on Form 10-Q
                       [] Transition Report on Form N-SAR

                        For the Transition Period Ended:

 If the notification relates to a portion of the filing checked above, identify
                 the Item(s) to which the notification relates:

                        PART I -- REGISTRANT INFORMATION

                         Renhuang Pharmaceuticals, Inc.
                         ------------------------------
                             Full Name of Registrant

             Nevada                  0-24512                88-1273503
(State or Other Jurisdiction     (Commission File        (I.R.S. Employer
       of Incorporation)              Number)             Identification
                                                             Number)

                       No. 218, Taiping, Taiping District
                          Harbin, Heilongjiang Province
                                P.R. China 150050
                    (Address of principal executive offices)

                               86 (451) 5762-0378
              (Registrant's telephone number, including area code)



                                 Not Applicable
          (Former name or former address, if changed since last report)

                       PART II -- RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)

       (a)  The reason described in reasonable detail in Part III of this
            form could not be eliminated without unreasonable effort or expense

       (b)  The subject annual report, semi-annual report, transition report on
            Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or
            portion thereof, will be filed on or before the fifteenth calendar
  |X|       day following the prescribed due date; or the subject quarterly
            report or transition report on Form 10-Q or subject distribution
            report on Form 10-D, or portion thereof, will be filed on or before
            the fifth calendar day following the prescribed due date; and

       (c)  The accountant's statement or other exhibit required by Rule
            12b-25(c) has been attached if applicable.

                              PART III -- NARRATIVE

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR,
N-CSR, or the transition report or portion thereof, could not be filed within
the prescribed time period:

      The registrant requires additional time to ensure the accuracy of the
information be included in the registrant's Form 10-Q.

                          PART IV -- OTHER INFORMATION

(1)   Name and telephone number of person to contact in regard to this
      notification

      Mr. Shaoming Li               011-86-451                    5762-0378
      ---------------               ----------                    ---------
          (Name)                    (Area Code)               (Telephone Number)

(2)   Have all other periodic reports required under Section 13 or 15(d) of the
      Securities Exchange Act of 1934 or Section 30 of the Investment Company
      Act of 1940 during the preceding 12 months or for such shorter period that
      the registrant was required to file such report(s) been filed? If answer
      is no, identify report(s).

      [x] Yes [ ] No

(3)   Is it anticipated that any significant change in results of operations
      from the corresponding period for the last fiscal year will be reflected
      by the earnings statements to be included in the subject report or portion
      thereof?

      [ ] Yes [x] No

      If so, attach an explanation of the anticipated change, both narratively
      and quantitatively, and, if appropriate, state the reasons why a
      reasonable estimate of the results cannot be made.




                         Renhuang Pharmaceuticals, Inc.
                         ------------------------------
                  (Name of Registrant as Specified in Charter)


      has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.

Date: March 16, 2009                    By:  /s/ Shaoming Li
                                             ----------------------------------
                                             Shaoming Li
                                             Title: Chief Executive Officer